News
Ocular Therapeutix is making sure its corporate vision is 20/20 as it looks forward to phase 3 data on its eye disease drug candidate Axpaxli. | Ocular Therapeutix is making sure its corporate vision ...
The global Ophthalmology Drugs Market , valued at US$18.34 billion in 2024 stood at US$19.52 billion in 2025 and is projected to advance at ...
The global Ophthalmology Drugs Market , valued at US$18.34 billion in 2024 stood at US$19.52 billion in 2025 and is projected ...
At the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) meeting held in Los Angeles, the top paper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback